Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Achieve Life Sciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 41 | 56 | +15 |
| Shares | 16.5M | 18.6M | +2.12M (+12.9%) |
| Value | $64.9M | $78.4M | +$13.5M (+20.8%) |
New holders (24)
Institutions that held Achieve Life Sciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (9)
Institutions that held Achieve Life Sciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 44,653 | $202.9K |
| Balyasny Asset Management LLC | 27,747 | $126.1K |
| Virtu Financial LLC | 12,930 | $59.0K |
| Omers Administration Corp | 12,000 | $54.5K |
| Jefferies Financial Group Inc. | 11,500 | $52.3K |
| Group One Trading, L.P. | 6,555 | $29.8K |
| Qube Research & Technologies Ltd | 4,029 | $18.3K |
| Northwestern Mutual Wealth Management Co | 5 | $23 |
| Macquarie Group Ltd | 1,047 | $5 |